Cystic fibrosis drug trial halted early
NCT ID NCT04375514
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called ARO-ENaC in healthy volunteers and people with cystic fibrosis. The goal was to see if it is safe and helps lung function. The trial was stopped early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS, PULMONARY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Nedlands, Washington, 6009, Australia
-
Research Site 2
Hamilton, 3204, Australia
-
Research Site 3
Chermside, Queensland, 4032, Australia
-
Research Site 4
South Brisbane, Queensland, 4101, Australia
-
Research Site 6
Grafton, Auckland, 1010, New Zealand
-
Research Site 7
Dunedin, 9054, New Zealand
-
Research Site 8
Christchurch, 8140, New Zealand
More trials for these conditions
Other studies related to the condition(s) this trial covers.